Phi Pharma SA

Swiss Biotech Association

Not a member
Claim / update listing

Phi Pharma SA is developing a new class of anti-cancer drugs: peptide drug conjugates effective in multiple human cancers using an innovative mechanism of cell entry: novel sugar-based drug targets.

https://www.phi-pharma.com/

Location

Place du Midi 36, 1950 Sion, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2012
Number of employees in Switzerland

1-9

Key business

Core competencies

You may also be interested in

Sintetica SA

Sintetica is a pharmaceutical company delivering injectable medicines to patients worldwide, through innovative science and excellence in development, production and marketing. The multicultural high-performing organization is built to support both the national growth and the global expansion.
Mendrisio

Member

Labatec Pharma SA

Labatec is a privately owned Swiss-based pharmaceutical company with more than 50 years of experience in delivering high quality products to the European and Emerging Markets. Covering both the hospital and retail sectors, we have a portfolio of over 65 products and a growing geographic footprint.
Meyrin

Member

GlycoEra AG

GlycoEra leverages its control over natural glycan-mediated pathways to advance novel drugs using its propriety platform, the CustumGlycan Platform. GlycoEra develops first in class therapeutics in inflammatory disease, autoimmune disorder and immuno-oncology indications.
8952 Schlieren

Member